Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Mayumi Nakagawa

Concepts (217)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Papillomavirus Infections
15
2024
155
4.760
 Why?
Human papillomavirus 16
11
2021
44
3.750
 Why?
Uterine Cervical Neoplasms
10
2024
276
3.490
 Why?
Papillomavirus Vaccines
7
2021
61
3.420
 Why?
Oncogene Proteins, Viral
11
2011
52
2.550
 Why?
Papillomaviridae
7
2019
102
2.410
 Why?
Repressor Proteins
9
2011
153
2.180
 Why?
Epitopes, T-Lymphocyte
7
2018
24
1.980
 Why?
Cancer Vaccines
3
2021
78
1.670
 Why?
T-Lymphocytes
6
2021
339
1.470
 Why?
Candida
4
2018
60
1.390
 Why?
CD8-Positive T-Lymphocytes
6
2018
128
1.350
 Why?
Cervix Uteri
3
2021
49
0.910
 Why?
Uterine Cervical Dysplasia
2
2015
49
0.870
 Why?
Immunity, Cellular
4
2013
70
0.760
 Why?
Lymphocytes, Tumor-Infiltrating
1
2021
78
0.750
 Why?
Epitopes
2
2015
61
0.730
 Why?
Langerhans Cells
3
2018
11
0.730
 Why?
Neoplasms
2
2021
1249
0.700
 Why?
Viral Load
2
2019
77
0.680
 Why?
Health Education
1
2021
155
0.670
 Why?
Cell Cycle Checkpoints
1
2019
32
0.670
 Why?
HLA Antigens
4
2006
53
0.640
 Why?
Colorectal Neoplasms
1
2021
236
0.610
 Why?
CD4-Positive T-Lymphocytes
3
2018
164
0.580
 Why?
Adult
20
2021
13324
0.580
 Why?
Humans
40
2024
50208
0.580
 Why?
Female
28
2024
26635
0.570
 Why?
Health Knowledge, Attitudes, Practice
1
2021
486
0.550
 Why?
Plasma Exchange
2
2014
23
0.530
 Why?
Cross Protection
1
2015
5
0.510
 Why?
T-Lymphocytes, Regulatory
2
2016
86
0.510
 Why?
Colposcopy
1
2015
18
0.490
 Why?
Interleukin-12
2
2018
31
0.490
 Why?
Adjuvants, Immunologic
2
2018
51
0.480
 Why?
Immunity, Innate
1
2015
105
0.470
 Why?
Interferon-gamma
2
2012
176
0.460
 Why?
Health
1
2013
23
0.460
 Why?
Lectins, C-Type
1
2013
30
0.460
 Why?
Papillomavirus E7 Proteins
8
2018
31
0.450
 Why?
Young Adult
9
2021
3981
0.450
 Why?
Patient Selection
1
2015
253
0.440
 Why?
Middle Aged
14
2021
12206
0.440
 Why?
Afibrinogenemia
1
2012
5
0.420
 Why?
Enzyme-Linked Immunospot Assay
1
2012
2
0.410
 Why?
T-Lymphocytes, Cytotoxic
4
2009
65
0.410
 Why?
Breast Neoplasms
1
2021
1179
0.400
 Why?
Vaginal Smears
3
2021
27
0.380
 Why?
Cell Proliferation
5
2021
1013
0.380
 Why?
Early Detection of Cancer
3
2021
167
0.370
 Why?
Warts
1
2010
13
0.370
 Why?
Plateletpheresis
1
2010
7
0.370
 Why?
Antigens, Fungal
1
2010
24
0.370
 Why?
Blood Preservation
1
2010
26
0.370
 Why?
Dermatitis
1
2010
36
0.360
 Why?
Blood Proteins
1
2010
82
0.360
 Why?
Anaphylaxis
1
2010
71
0.350
 Why?
Cells, Cultured
5
2021
1581
0.330
 Why?
Antigens, Viral
2
2009
44
0.320
 Why?
Immunotherapy
1
2010
240
0.320
 Why?
Telemedicine
1
2015
449
0.320
 Why?
Human papillomavirus 18
1
2008
9
0.310
 Why?
Blood Platelets
1
2010
249
0.310
 Why?
Host-Pathogen Interactions
2
2021
135
0.300
 Why?
Vaccinia virus
1
2007
6
0.290
 Why?
Dendritic Cells
1
2008
133
0.290
 Why?
Immunoenzyme Techniques
1
2007
145
0.280
 Why?
Immunophenotyping
1
2007
109
0.280
 Why?
Isoantibodies
1
2004
25
0.240
 Why?
Cell Line, Tumor
5
2021
1416
0.240
 Why?
Neoplasm Grading
2
2021
123
0.240
 Why?
Aged
9
2021
9405
0.240
 Why?
Lead
1
2004
34
0.240
 Why?
Infant, Very Low Birth Weight
1
2004
47
0.230
 Why?
Neutropenia
1
2004
115
0.230
 Why?
DNA, Viral
3
2011
134
0.230
 Why?
Oropharyngeal Neoplasms
1
2024
19
0.230
 Why?
Anus Neoplasms
1
2024
24
0.230
 Why?
Coinfection
1
2024
38
0.220
 Why?
Blood Transfusion
1
2004
126
0.220
 Why?
Penile Neoplasms
1
2024
45
0.220
 Why?
Adolescent
5
2021
6390
0.220
 Why?
High-Throughput Nucleotide Sequencing
2
2021
170
0.220
 Why?
Capsid Proteins
1
2002
24
0.210
 Why?
Antibody Formation
1
2002
52
0.210
 Why?
Genes, T-Cell Receptor
1
2021
5
0.200
 Why?
Clone Cells
3
2007
78
0.200
 Why?
Treatment Outcome
3
2021
5155
0.200
 Why?
Clinical Trials, Phase I as Topic
1
2021
25
0.200
 Why?
Cytokines
2
2016
613
0.200
 Why?
Pilot Projects
2
2021
697
0.190
 Why?
Remission Induction
1
2021
207
0.190
 Why?
Mass Screening
2
2021
346
0.190
 Why?
Cystadenocarcinoma, Serous
1
2021
71
0.190
 Why?
Left-Right Determination Factors
1
2020
1
0.190
 Why?
Nodal Protein
1
2020
3
0.190
 Why?
Lymphocyte Activation
1
2021
172
0.190
 Why?
Videotape Recording
1
2021
28
0.190
 Why?
Amino Acid Sequence
3
2008
586
0.180
 Why?
Mammography
1
2021
94
0.180
 Why?
Focus Groups
1
2021
191
0.180
 Why?
Enzyme-Linked Immunosorbent Assay
3
2010
244
0.170
 Why?
Male
10
2024
25399
0.170
 Why?
Metagenome
1
2019
40
0.170
 Why?
Glioblastoma
1
2020
93
0.160
 Why?
Feasibility Studies
1
2021
380
0.160
 Why?
Parenteral Nutrition
1
2019
27
0.160
 Why?
Dose-Response Relationship, Drug
2
2016
1378
0.160
 Why?
Up-Regulation
1
2020
453
0.160
 Why?
Health Behavior
1
2021
253
0.160
 Why?
Transplantation Conditioning
1
2019
84
0.160
 Why?
DNA
1
2021
541
0.150
 Why?
Time Factors
2
2021
2922
0.150
 Why?
Bacteria
1
2019
222
0.150
 Why?
Leukocytes, Mononuclear
2
2016
115
0.150
 Why?
HLA-B Antigens
2
2008
6
0.150
 Why?
Multiple Myeloma
1
2012
2954
0.150
 Why?
Age Factors
1
2021
1092
0.150
 Why?
Cell Line
2
2012
1021
0.150
 Why?
Ovarian Neoplasms
1
2021
447
0.140
 Why?
Brain Neoplasms
1
2020
288
0.140
 Why?
Histocompatibility Antigens Class II
2
2008
36
0.140
 Why?
Head and Neck Neoplasms
1
2019
273
0.140
 Why?
Vaccines, Subunit
1
2016
15
0.140
 Why?
Body Mass Index
1
2019
656
0.130
 Why?
Molecular Sequence Data
2
2008
793
0.130
 Why?
Adaptive Immunity
1
2015
32
0.130
 Why?
Chromatography, Liquid
1
2016
225
0.120
 Why?
Leukocyte Count
2
2004
72
0.120
 Why?
Peptides
2
2006
223
0.120
 Why?
Tandem Mass Spectrometry
1
2016
231
0.120
 Why?
Factor VIII
1
2014
23
0.120
 Why?
Purpura, Thrombotic Thrombocytopenic
1
2014
15
0.120
 Why?
ADAM Proteins
1
2014
20
0.120
 Why?
Proteome
1
2016
173
0.120
 Why?
Antigens, CD1
1
2013
9
0.120
 Why?
Mannose-Binding Lectins
1
2013
10
0.120
 Why?
Receptors, Pattern Recognition
1
2013
4
0.120
 Why?
Indicators and Reagents
1
2013
37
0.120
 Why?
Intracellular Space
1
2013
25
0.110
 Why?
Vaccination
1
2016
271
0.110
 Why?
Skin Tests
1
2013
58
0.110
 Why?
Hematopoietic Stem Cell Transplantation
1
2019
567
0.110
 Why?
Cadherins
1
2013
68
0.110
 Why?
Proteomics
1
2016
330
0.110
 Why?
Communication
1
2015
246
0.110
 Why?
Rural Health Services
1
2015
164
0.110
 Why?
Research Design
1
2015
342
0.100
 Why?
Socioeconomic Factors
1
2015
579
0.100
 Why?
Antigens, CD
1
2013
221
0.100
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2013
595
0.100
 Why?
Longitudinal Studies
2
2005
695
0.100
 Why?
Injections, Intralesional
1
2010
31
0.090
 Why?
Isotonic Solutions
1
2010
18
0.090
 Why?
Platelet Transfusion
1
2010
28
0.090
 Why?
P-Selectin
1
2010
32
0.090
 Why?
Sodium Chloride
1
2010
58
0.090
 Why?
Platelet Aggregation
1
2010
71
0.090
 Why?
Platelet Activation
1
2010
47
0.090
 Why?
Hypersensitivity
1
2010
77
0.090
 Why?
Retrospective Studies
3
2019
6134
0.080
 Why?
Polymerase Chain Reaction
1
2010
454
0.080
 Why?
HLA-A Antigens
1
2008
10
0.080
 Why?
Antigen Presentation
1
2008
25
0.080
 Why?
Immunologic Memory
1
2008
30
0.080
 Why?
Histocompatibility Antigens Class I
1
2008
44
0.080
 Why?
Signal Transduction
2
2020
1622
0.080
 Why?
DNA, Recombinant
1
2007
15
0.070
 Why?
Genes, MHC Class I
1
2006
11
0.070
 Why?
Animals
2
2019
13246
0.070
 Why?
Arkansas
1
2013
1985
0.070
 Why?
Binding, Competitive
1
2006
94
0.070
 Why?
Neoplasm Staging
1
2008
738
0.060
 Why?
Calgranulin B
1
2005
4
0.060
 Why?
Calgranulin A
1
2005
5
0.060
 Why?
Immunomagnetic Separation
1
2004
7
0.060
 Why?
Epitope Mapping
1
2004
6
0.060
 Why?
Risk Factors
1
2013
3629
0.060
 Why?
Phosphorylation
2
2020
534
0.050
 Why?
Sensitivity and Specificity
1
2005
863
0.050
 Why?
Tumor Virus Infections
1
2002
42
0.050
 Why?
Antibodies, Viral
1
2002
88
0.050
 Why?
Lactobacillus
1
2021
7
0.050
 Why?
Immunoglobulin G
1
2002
186
0.050
 Why?
SOX Transcription Factors
1
2021
4
0.050
 Why?
Neuroendocrine Cells
1
2021
10
0.050
 Why?
Biological Specimen Banks
1
2021
21
0.050
 Why?
Cytodiagnosis
1
2021
42
0.050
 Why?
Cytoplasm
1
2021
91
0.050
 Why?
Cobalt
1
2020
16
0.050
 Why?
Recurrence
1
2002
662
0.050
 Why?
Vulnerable Populations
1
2020
45
0.050
 Why?
Cohort Studies
1
2004
1422
0.050
 Why?
Epithelial-Mesenchymal Transition
1
2020
48
0.050
 Why?
Cell Hypoxia
1
2020
82
0.050
 Why?
Neoplastic Stem Cells
1
2021
103
0.040
 Why?
Cell Movement
1
2021
249
0.040
 Why?
Community Health Workers
1
2020
51
0.040
 Why?
Multivariate Analysis
1
2021
581
0.040
 Why?
Parenteral Nutrition, Total
1
2019
31
0.040
 Why?
Sequence Analysis, DNA
1
2019
238
0.040
 Why?
Cell Survival
1
2020
602
0.040
 Why?
Phenotype
1
2021
733
0.040
 Why?
Cell Differentiation
1
2021
650
0.040
 Why?
Linear Models
1
2019
278
0.040
 Why?
Immunity, Humoral
1
2018
22
0.040
 Why?
Models, Biological
1
2021
723
0.040
 Why?
Infant, Newborn
1
2004
2766
0.040
 Why?
Gene Expression Regulation, Neoplastic
1
2020
828
0.030
 Why?
Prognosis
1
2021
1954
0.030
 Why?
Autoantibodies
1
2014
116
0.030
 Why?
Immunosuppressive Agents
1
2014
222
0.030
 Why?
Mice, Inbred C57BL
1
2018
1819
0.030
 Why?
Combined Modality Therapy
1
2014
636
0.030
 Why?
Mice
1
2018
5759
0.020
 Why?
Casein Kinase II
1
2005
10
0.020
 Why?
Cell Division
1
2005
295
0.010
 Why?
Nakagawa's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (217) concept(s)
_
Co-Authors Expand Description
See all (26) people
_
Similar People Expand Description
See all (36) people
_
Same Department Expand Description
Search Department